📰 Iagnostics News
Page 52 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
December 22, 2022
Two companion studies report new artificial intelligence approaches for identification of molecular "fingerprints" for specific infections. The methods, used here to derive a fingerprint for COVID-19, can advance the development of rapid diagnostics for many infectious diseases.
December 22, 2022
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "AI in Genomics Market by Offering (Software, Services), Functionality (Sequencing, Gene Editing),...
December 22, 2022
EKF Diagnostics , a global in vitro diagnostics company, announces the launch of a new version of its Lactate Scout analyzer, designed specifically for use in veterinary settings.
December 21, 2022
Lupin Diagnostics expands footprint; launches regional reference lab in Indore
December 21, 2022
Dublin, Dec. 21, 2022 (GLOBE NEWSWIRE) -- The "Cardiac Troponin Diagnostics - Forecasts and Opportunities to 2025" report has been added to ...
December 20, 2022
The US Food and Drug Administration (FDA) has approved Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations who may benefit from treatment with KRAZATITM (adagrasib). Click to read more...
December 20, 2022
Forays into diagnostics business with Indira PathLabs
December 18, 2022
New research at Cleveland Clinic expands the link between what we eat and how the gut microbiome impacts our susceptibility to develop different diseases – in this case, how a specific gut microbe-generated byproduct is linked to heart failure risk.
December 16, 2022
Researchers at the University of Miami Miller School of Medicine, McGill University and other institutions have found that a well-concealed genetic variation in the gene FGF14, called a DNA tandem repeat expansion, causes a common form of late-onset cerebellar ataxia, a brain disorder that interferes with coordinated movement.
December 16, 2022
With modern therapies for heart failure (HF) with reduced ejection fraction (HFrEF), some patients can improve their cardiac function during treatment. But despite this improvement in the ability of their hearts to pump, these patients with so called heart failure with improved ejection fraction (HFimpEF) remain at high risk for adverse outcomes.